Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-417068

See Remarks sold 58,333 shares at an average $12.92 ($753,937)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kirn David See Remarks 2026-10-05 Sale 10b5-1 −58,061 $12.92 $750,235 709,425 D: show line 1 in the form
Kirn David See Remarks 2026-10-05 Sale 10b5-1 −272 $13.61 $3,702 709,153 D: show line 2 in the form
Open-market sales · 58,333 sh · avg $12.92 · $753,937
Loading xslF345X06/ownership.xml…